HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas.
Guzzo F, Bellone S, Buza N, Hui P, Carrara L, Varughese J, Cocco E, Betti M, Todeschini P, Gasparrini S, Schwartz PE, Rutherford TJ, Angioli R, Pecorelli S, Santin AD.
Guzzo F, et al. Among authors: hui p.
Int J Gynecol Pathol. 2012 May;31(3):211-21. doi: 10.1097/PGP.0b013e31823bb24d.
Int J Gynecol Pathol. 2012.
PMID: 22498937
Free PMC article.